Abstract
A series of oxadiazole incorporated ellipticine derivatives were synthesized and evaluated for their anticancer activity on human cancer cell lines Colo-205, MCF-7, A-549, and KB. Five of the newly synthesized target products exhibited potent cytotoxic activities with GI50 values ranging from <0.1 to 23.6 µM, where the positive control etoposide showed GI50 values ranging from 0.13 to 3.08 µM.
Graphical abstract
Similar content being viewed by others
References
WHO World Cancer Report 2014 (2013). http://www.nydailynews.com/life-style/health/14-million-people-cancer-2012-article-1.1545738. Accessed 12 Dec 2013
Aydemir N, Bilaloglu R (2003) Mutat Res 537:43
Goodwin S, Smith AF, Horning EC (1959) J Am Chem Soc 81:1903
Stiborova M, Bieler CA, Wiessler M, Frei E (2001) Biochem Pharmacol 62:1675
Stiborova M, Rupertova M, Schmeiser HH, Frei E (2006) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150:13
Stiborova M, Rupertova M, Frei E (2011) Biochim Biophys Acta 1814:175
Reddy NB, Burra VR, Ravindranath LK, Kumar VN, Sreenivasulu R, Sadanandam P (2016) Monatsh Chem 147:599
Auclair C (1987) Arch Biochem Biophys 259:1
Singh MP, Hill GC, Peoch D, Rayner B, Inabach JL, Lown JW (1994) Biochemistry 33:10271
Chu Y, Hsu MT (1992) Nucleic Acids Res 20:4033
Monnot M, Mauffret O, Simon V, Lescot E, Psaume B, Saucier JM, Charra M, Belehradek J Jr, Fermandjian S (1991) J Biol Chem 25:1820
Fosse P, Rene B, Charra M, Paoletti C, Saucier JM (1992) Mol Pharmacol 42:590
Woodward RB, Iacobucci GA, Hochstein FA (1959) J Am Chem Soc 81:4434
Garbett NC, Graves DE (2004) Curr Med Chem 4:149
Stiborova M, Rupertova MS, Dohalska MB, Weissler M, Frei E (2003) Chem Res Toxicol 16:38
Malleshappa NN, Harun MP (2012) Eur J Med Chem 56:56
Asati V, Mahapatra DK, Bharti SK (2014) Eur J Med Chem 87:814
Hatti I, Sreenivasulu R, Jadav SS, Jayaprakash V, Kumar CG, Raju RR (2015) Med Chem Res 24:3305
Reddy NB, Burra VR, Ravindranath LK, Sreenivasulu R, Kumar VN (2016) Monatsh Chem 147:593
Sreenivasulu R, Sujitha P, Jadav SS, Ahsan MJ, Kumar CG, Raju RR (2016) Monatsh Chem. doi:10.1007/s00706-016-1750-6
Ahsan MJ, Choudhary K, Jadav SS, Yasmin S, Ansari MY, Sreenivasulu R (2015) Med Chem Res 24:4166
Farshori NN, Banday MR, Ahmad A, Khan AU, Rauf A (2010) Bioorg Med Chem Lett 20:1933
Cui ZN, Shi YX, Zhang L, Ling Y, Li BJ, Nishida Y, Yang XL (2012) J Agric Food Chem 60:11649
Li YH, Zhu HJ, Chen K, Liu R, Khallaf A, Zhang XN, Ni JP (2013) Org Biomol Chem 11:3979
El-Emam AA, Al-Deeb OA, Al-Omar M, Lehmann J (2004) Bioorg Med Chem 12:5107
Jayashankar B, Lokanathrai KM, Baskaran N, Sathish HS (2009) Eur J Med Chem 44:3898
Kucukguzel SG, Oruc EE, Rollas S, Sahin F, Ozbek A (2002) Eur J Med Chem 37:197
Bondock S, Adel S, Etman HA, Badria FA (2012) Eur J Med Chem 48:192
Hatti I, Sreenivasulu R, Jadav SS, Ahsan MJ, Raju RR (2015) Monatsh Chem 146:1699
Zibotentan James ND, Growcott JW (2009) Drugs Future 34:624
Skehn P, Storeng R, Scudiero A, Monks J, McMohan D, Vistica D, Jonathan WT, Bokesch H, Kenney S, Boyd RM (1990) J Natl Cancer Inst 82:1107
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Madhavi, S., Sreenivasulu, R. & Raju, R.R. Synthesis and biological evaluation of oxadiazole incorporated ellipticine derivatives as anticancer agents. Monatsh Chem 148, 933–938 (2017). https://doi.org/10.1007/s00706-016-1790-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-016-1790-y